MoonLake raises CEO, CSO, CFO salaries and bonuses citing MIRA trial success

MoonLake Immunotherapeutics

New annual base salaries July 1, 2023: CEO Jorge Santos da Silva CHF 600k (was CHF 450k), CSO Kristian Reich CHF 600k (was CHF 450k), CFO Matthias Bodenstedt CHF 475k (was CHF 325k).
Target bonuses raised to 55% of salary for CEO and CSO, 50% for CFO (previously 50%, 50%, 40% respectively).
Board cites positive Phase 2 MIRA trial results and peer benchmarking as rationale for adjustments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.